PMGC HOLDINGS INC. Legal Fees
PMGC HOLDINGS INC. (ELAB) reported Legal Fees of $12.32 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2026-03-30
- PMGC HOLDINGS INC. legal fees for the quarter ending 2025-12-31 was $0.00.
- PMGC HOLDINGS INC. legal fees for the quarter ending 2025-09-30 was $0.00.
- PMGC HOLDINGS INC. legal fees for the quarter ending 2025-06-30 was $0.00.
- PMGC HOLDINGS INC. legal fees for the quarter ending 2025-03-31 was $12.32K.
- PMGC HOLDINGS INC. legal fees for fiscal 2025 was $12.32K, a 0.00% change from fiscal 2024.
- PMGC HOLDINGS INC. legal fees for fiscal 2024 was $12.32K, a 188.39% increase from fiscal 2023.
- PMGC HOLDINGS INC. legal fees for fiscal 2023 was $4.27K, a 43.79% increase from fiscal 2022.
- PMGC HOLDINGS INC. legal fees for fiscal 2022 was $2.97K.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | $12.32K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $12.32K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $12.32K 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $12.32K 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $12.32K 10-K · filed 2025-03-28 | |||
| 2023-12-31 | $4.27K 10-K · filed 2024-03-29 | |||
| 2022-12-31 | $2.97K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |